ElsevierDrugInformation
OnabotulinumtoxinA Injection
Learn more about Elsevier’s Drug Patient Education today! Empower and engage your patients to use medication safely.
ONABOTULINUMTOXINA (o na BOTT you lye num tox in eh) treats severe muscle spasms. It may also be used to prevent migraine headaches. It can treat excessive sweating when other medications do not work well enough.
This medication is for injected into a muscle. It is given by your care team in a hospital or clinic setting.
A special MedGuide will be given to you before each treatment. Be sure to read this information carefully each time.
Talk to your care team about the use of this medication in children. While this medication may be prescribed for children as young as 2 years for selected conditions, precautions do apply.
Side effects that you should report to your care team as soon as possible:
Side effects that usually do not require medical attention (report these to your care team if they continue or are bothersome):
This medication is given in a hospital or clinic and will not be stored at home.
They need to know if you have any of these conditions:
This does not apply.
Visit your care team for regular check ups.
This medication will cause weakness in the muscle where it is injected. Tell your care team if you feel unusually weak in other muscles. Get medical help right away if you have problems with breathing, swallowing, or talking.
This medication might make your eyelids droop or make you see blurry or double. If you have weak muscles or trouble seeing do not drive a car, use machinery, or do other dangerous activities.
This medication contains albumin from human blood. It may be possible to pass an infection in this medication, but no cases have been reported. Talk to your care team about the risks and benefits of this medication.
If your activities have been limited by your condition, go back to your regular routine slowly after treatment with this medication.
Cookies are used by this site. To decline or learn more, visit our cookie notice.
Copyright © 2024 Elsevier, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies.